Whole-exome sequencing in pediatric drug-resistant epilepsy: diagnostic yield and clinical impact in a resource-limited setting
Neurogenetics · 2026
DOI: 10.1007/s10048-026-00932-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogenetics, 2026. Verfasst von Elisabeth Siti Herini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 552…. Hauptthemen laut MEDLINE: Exome Sequencing, Drug Resistant Epilepsy. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Indonesian Ministry of Education, Culture, Research, and Technology.
Abstract (Originalsprache)
Drug-resistant epilepsy (DRE) in children is linked to poor developmental outcomes and increased mortality. Genetic factors are increasingly recognized in its pathogenesis, and whole- exome sequencing (WES) offers a promising diagnostic tool for early intervention, especially in cases with unclear etiology. However, data on the genetic causes of pediatric DRE remain scarce in Indonesia, a low-resource setting with limited access to advanced genetic testing. We conducted a retrospective review at the Neuropediatric Clinic of Sardjito Hospital, Yogyakarta, Indonesia, from January to December 2024. Children aged 0–18 years at the time of epilepsy diagnosis or genetic testing were included. WES was performed for all patients, and in cases with positive findings, Sanger sequencing was used to confirm variants in parents and siblings. WES identified pathogenic or likely pathogenic variants in 3 of 10 patients, with one patient harboring three variants. In total, three pathogenic or likely pathogenic variants were identified in TSC2, CC2D2A, and WDFY3, and two variants of uncertain significance were identified in CC2D2A and ATP6V1A. Among the five variants, two were missense mutations, two were nonsense mutations, and one was a frameshift mutation. WES can yield a definitive genetic diagnosis in a subset of patients, enabling individualized management, facilitating genetic counseling, and reducing the need for further diagnostic investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Neurology, Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
- Division of Pediatric Neurology, Department of Child Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia. agung.triono@ugm.ac.id.
- Genetics Working Group/Translational Research Unit, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Förderung
- Indonesian Ministry of Education, Culture, Research, and Technology
Zitieren
APA
Herini, E. S., Triono, A., Iskandar, K., Nugrahanto, A. P., Damroni, R. A., Mooiindie, K. H., & Timoti, J. (2026). Whole-exome sequencing in pediatric drug-resistant epilepsy: diagnostic yield and clinical impact in a resource-limited setting. Neurogenetics. https://doi.org/10.1007/s10048-026-00932-0
Vancouver
Herini ES, Triono A, Iskandar K, Nugrahanto AP, Damroni RA, Mooiindie KH, et al. Whole-exome sequencing in pediatric drug-resistant epilepsy: diagnostic yield and clinical impact in a resource-limited setting. Neurogenetics. 2026. doi:10.1007/s10048-026-00932-0
BibTeX
@article{Herini2026,
author = {Herini, Elisabeth Siti and Triono, Agung and Iskandar, Kristy and Nugrahanto, Andika Priamas and Damroni, Rais Aliffandy and Mooiindie, Khansadhia Hasmaradana and Timoti, Joshua},
title = {Whole-exome sequencing in pediatric drug-resistant epilepsy: diagnostic yield and clinical impact in a resource-limited setting},
journal = {Neurogenetics},
year = {2026},
doi = {10.1007/s10048-026-00932-0}
}
EUVIMED